Dr. Abdullateef '. Abdulkareem
Overview
Abdullateef Abdulkareem is a Hematologist and an Oncologist practicing medicine in Lancaster, Pennsylvania.
His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, and Fasciotomy.
Dr. Abdulkareem is board certified in Hematology, 2022, Medical Oncology, 2022, and Internal Medicine, 2018. He is actively involved in clinical research, co-authoring 8 peer reviewed articles. Dr. Abdulkareem is currently accepting new patients.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE PDP
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2102 Harrisburg Pike, Lancaster, PA 17601
Additional Areas of Focus
Dr. Abdulkareem has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Office
Taofeek Owonikoko is a Hematologist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Owonikoko is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Tissue Biopsy.
Office
Janet Kwiatkowski is a Hematologist and an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Kwiatkowski is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Hemolytic Anemia, Congenital Hemolytic Anemia, Hemoglobinopathy, Bone Marrow Transplant, and Splenectomy.
Johns Hopkins Bayview Medical Center
Patrick Forde is a Hematologist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Forde is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Mesothelioma, and Small Cell Lung Cancer (SCLC).
Frequently Asked Questions about Dr. Abdullateef '. Abdulkareem
How do I make an appointment with Dr. Abdullateef '. Abdulkareem?
You can book an appointment with Dr. Abdullateef '. Abdulkareem by calling their office at 717-544-9400. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Abdullateef '. Abdulkareem a top-rated expert for Chronic Lymphocytic Leukemia (CLL)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Abdullateef '. Abdulkareem is classified as an Experienced expert for Chronic Lymphocytic Leukemia (CLL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Abdullateef '. Abdulkareem specialize in?
While Dr. Abdullateef '. Abdulkareem is a Hematology, they have specific expertise in Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), and Diffuse Large B-Cell Lymphoma (DLBCL). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Abdullateef '. Abdulkareem participate in research or clinical trials?
Yes. Dr. Abdullateef '. Abdulkareem has published 8 articles and abstracts on conditions like Chronic Lymphocytic Leukemia (CLL). You can view a list of Dr. Abdullateef '. Abdulkareem's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Abdullateef '. Abdulkareem accept my insurance?
Dr. Abdullateef '. Abdulkareem accepts most major insurance plans, including Aetna and Avalon Health Care. We recommend calling the office directly at 717-544-9400 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Hepatic Porphyria (AHP)Dr. Abdulkareem isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Intermittent PorphyriaDr. Abdulkareem isExperienced. Learn about Acute Intermittent Porphyria.
- Acute Mountain SicknessDr. Abdulkareem isExperienced. Learn about Acute Mountain Sickness.
- Adult Immune ThrombocytopeniaDr. Abdulkareem isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Abdulkareem isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Abdulkareem isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.